Paradoxical Acinetobacter-associated ventilator-associated pneumonia incidence rates within prevention studies using respiratory tract applications of topical polymyxin: benchmarking the evidence base.
Hurley, J C
Paradoxical Acinetobacter-associated ventilator-associated pneumonia incidence rates within prevention studies using respiratory tract applications of topical polymyxin: benchmarking the evidence base. [electronic resource] - The Journal of hospital infection Sep 2018 - 105-113 p. digital
Publication Type: Journal Article
1532-2939
10.1016/j.jhin.2018.04.005 doi
Acinetobacter Infections--epidemiology
Anti-Bacterial Agents--administration & dosage
Antibiotic Prophylaxis--methods
Benchmarking
Humans
Incidence
Pneumonia, Ventilator-Associated--epidemiology
Polymyxins--administration & dosage
Paradoxical Acinetobacter-associated ventilator-associated pneumonia incidence rates within prevention studies using respiratory tract applications of topical polymyxin: benchmarking the evidence base. [electronic resource] - The Journal of hospital infection Sep 2018 - 105-113 p. digital
Publication Type: Journal Article
1532-2939
10.1016/j.jhin.2018.04.005 doi
Acinetobacter Infections--epidemiology
Anti-Bacterial Agents--administration & dosage
Antibiotic Prophylaxis--methods
Benchmarking
Humans
Incidence
Pneumonia, Ventilator-Associated--epidemiology
Polymyxins--administration & dosage